Katherine Cooper
Appearances
DateMay 18, 2024Introduction: There is increasing data to support the beneficial effects of statin medications on liver disease including reducing the development of hepatic fibrosis in metabolic associated steatotic liver disease (MASLD)/metabolic associated steatohepatitis (MASH) and reducing mortality in patien…Presenter
DateMay 18, 2024SOCIETY: AGA Newer and novel tools in understanding and management of patients with MASLDModerators
Beth Israel Deaconess Medical CenterVirginia Commonwealth Univ.Speakers
